<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-128626" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nuclear Medicine Musculoskeletal Assessment, Protocols, and Interpretation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Andre</surname>
            <given-names>Lincoln</given-names>
          </name>
          <aff>LSU Health Shreveport</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Clark</surname>
            <given-names>Michael D.</given-names>
          </name>
          <aff>Ochsner LSU Shreveport</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Accardo</surname>
            <given-names>Shaun I.</given-names>
          </name>
          <aff>LSU Health Shreveport</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Lincoln Andre declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Clark declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shaun Accardo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>10</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-128626.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Nuclear medicine imaging is a valuable tool in the diagnosis of musculoskeletal system disorders and pathology. It is commonly utilized to diagnose soft tissue and bony infections, neoplasms, and traumatic injury. This activity reviews the modalities and interpretation of nuclear medicine imaging in the evaluation of musculoskeletal disorders and will highlight the role of the interprofessional team in the use of nuclear medicine imaging.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify common nuclear medicine imaging modalities available for musculoskeletal evaluation.</p></list-item><list-item><p>Identify the indications for musculoskeletal nuclear medicine imaging tests.</p></list-item><list-item><p>Determine&#x000a0;the diagnostic significance of the findings of these tests.</p></list-item><list-item><p>Implement&#x000a0;common nuclear medicine imaging tests, in collaboration with the interprofessional team, to minimize the risk of unnecessary radiation exposure to patients.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=128626&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=128626">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-128626.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>
<bold>Bone Scan </bold>
</p>
        <p>The use of radioactive substances in evaluating the musculoskeletal system has a relatively long history. Early researchers explored the metabolic activity of bone using phosphorus-32 and autoradiography.<xref ref-type="bibr" rid="article-128626.r1">[1]</xref>&#x000a0;Further research explored the uptake of radiogallium by various skeletal tissues, including bone tumors, and demonstrated increased uptake before radiographic changes were visible.<xref ref-type="bibr" rid="article-128626.r2">[2]</xref><xref ref-type="bibr" rid="article-128626.r3">[3]</xref><xref ref-type="bibr" rid="article-128626.r4">[4]</xref>&#x000a0;In 1971, 99mTc 99m polyphosphate was introduced as a readily available and inexpensive bone scanning agent.<xref ref-type="bibr" rid="article-128626.r5">[5]</xref>&#x000a0;This became the basis of many tracers, including 99mTc-methylene diphosphonate and hydroxymethylene diphosphonate.</p>
        <p>Bone scan, or bone scintigraphy, uses radiopharmaceuticals consisting of a radionuclide bound to members of the phosphate family, the most common form being 99mTc-methylene diphosphonate (99mTc-MDP). Bone scintigraphy is exquisitely sensitive to bone turnover, detecting as little as a 5% change.<xref ref-type="bibr" rid="article-128626.r6">[6]</xref>&#x000a0;In specific instances, this can provide evidence of bone disease or dysfunction before bony changes are appreciated on conventional radiography.<xref ref-type="bibr" rid="article-128626.r7">[7]</xref>&#x000a0;</p>
        <p>Uptake can be seen with multiple conditions, including fracture, malignancy, and infection. Other disorders of bone turnover can also be seen, such as fibrous dysplasia and avascular necrosis. Certain scan phases can show soft tissue conditions such as cellulitis and complex regional pain syndrome. "Cold spots" may be caused by areas of decreased bone turnover seen with certain tumors and bone abscesses or caused by decreased blood flow, such as in frostbite, gangrene, or avascular necrosis.&#x000a0;</p>
        <p>Single-photon emission computed tomography (SPECT), which can also be combined with conventional CT images (SPECT/CT), is an adjunct to bone scintigraphy and typically allows for more accurate anatomic localization of lesions.</p>
        <p>
<bold>Gallium-67 Scintigraphy </bold>
</p>
        <p>Gallium-67 citrate emerged as one of the earliest tracers in musculoskeletal tumor and infection imaging. It was commonly used with bone scintigraphy, and results are based on the uptake patterns of the&#x000a0;2 tracers.<xref ref-type="bibr" rid="article-128626.r8">[8]</xref>&#x000a0;Gallium-67 imaging is a well-established modality with a 65 to 80% sensitivity for osteomyelitis when combined with bone scintigraphy. This radionuclide has a half-life of 78 hours, requiring a 2&#x000a0;to 3-day delay between administration and imaging, making imaging logistically difficult. Ga-67, in combination with SPECT, is currently used to diagnose spondylodiscitis, although more recent literature suggests the superiority of fluorine-18 2'-deoxy-2-fluoro-D-glucose PET (FDG/PET) scans in this indication.<xref ref-type="bibr" rid="article-128626.r9">[9]</xref><xref ref-type="bibr" rid="article-128626.r10">[10]</xref>&#x000a0;Gallium-67 is currently infrequently used.&#x000a0;</p>
        <p>
<bold>In Vitro Labeled Leukocytes and Bone Marrow Imaging </bold>
</p>
        <p>The radiolabeling of leukocytes to localize musculoskeletal infection has been used for the past&#x000a0;3 decades with great success. Indium-111 and 99mTc labeled hexamethylpropylene amine oxime (99mTc-HMPAO) are the most commonly used radiotracers. There are several differences between the&#x000a0;2 isotopes used for labeled leukocyte scintigraphy. The advantages of Indium-111 are a limited normal distribution and stability of the label, which allows delayed imaging. 99mTc-HMPAO, in contrast, has a large normal distribution, including liver, lungs, spleen, gastrointestinal system, and urinary tract, but offers higher resolution images. Radiation exposure to the patient is significantly lower when using 99mTc-HMPAO.</p>
        <p>Variability in intramedullary bone marrow distribution from fractures or hardware can lead to difficulty differentiating infection from normal active marrow when investigating infection of the bone. In these instances, utilizing a 99mTc-Sulfur Colloid scan can differentiate the two. Both labeled leukocytes and 99mTc-sulfur colloid show activity in the normal bone marrow. Still, infection changes the intraosseous environment so that 99mTc-sulfur colloid is not taken up by phagocytes and is cleared from the marrow in these areas, therefore showing no activity in areas of infection.<xref ref-type="bibr" rid="article-128626.r11">[11]</xref>&#x000a0;</p>
        <p>The test is positive when the labeled&#x000a0;white blood cell scan shows activity absent on the 99mTc-sulfur colloid scan. Drawbacks to leukocyte scintigraphy include delayed results and in-vitro blood handling for the labeling process, described in more detail below.&#x000a0;</p>
        <p>
<bold><bold>Fluorodeoxyglucose&#x02013;</bold>Positron Emission Tomography&#x000a0;&#x000a0;</bold>
</p>
        <p>Positron emission tomography (PET) is a nuclear medicine imaging modality that uses 18-F&#x000a0;fluorodeoxyglucose (FDG) as a tracer. It is based on the detection of photons that are produced during radionuclide decay. Positrons are emitted from the nucleus of the radionuclide during decay, producing&#x000a0;2 annihilation photons, which are detected by the scanner. After administration, the tracer enters cells by glucose transporters (GLUTs) and is phosphorylated to FDG-6-phosphate. Uptake is primarily dependent on glucose transporter concentration and cellular metabolic activity. FDG-6-phosphate cannot be further metabolized in the glycolytic pathway and accumulates in the cell.<xref ref-type="bibr" rid="article-128626.r12">[12]</xref>&#x000a0;</p>
        <p>Glucose-6-phosphatase normally dephosphorylates FDG, allowing it to leave the cell. Tumor cells commonly exhibit decreased glucose-6-phosphatase concentrations, which may cause cells to retain tracer for longer periods, leading to detection using the delayed scan technique.<xref ref-type="bibr" rid="article-128626.r13">[13]</xref>&#x000a0;</p>
        <p>FDG is a nonspecific tracer, showing uptake in many tissues with increased glucose transporters, such as the muscles, heart, GI tract, urinary tract, and brain. Uptake in other organs and the bony skeleton is normally low. Normal bone marrow does not exhibit significant uptake; therefore, active inflammatory infiltrates can be easily distinguished from hematopoietic marrow. States of active inflammation show increased uptake due to the increased concentration of glucose transporters in active inflammatory cells.</p>
        <p>FDG-PET provides some advantages to other forms of nuclear musculoskeletal imaging. It provides prompt results, typically around&#x000a0;2 hours after tracer injection. It is not distorted or affected by metal implants and offers a relatively high resolution of 4&#x000a0;to 5 mm. In the form of PET/CT, 3-dimensional localization and anatomic correlation improve.</p>
      </sec>
      <sec id="article-128626.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>99mTc-methylene diphosphonate complexes used in bone scintigraphy bind to the hydroxyapatite crystal in bone and quickly clear from soft tissue.<xref ref-type="bibr" rid="article-128626.r14">[14]</xref>&#x000a0;The uptake rate of these radiotracers is primarily dependent on bone turnover and secondarily on local blood flow.<xref ref-type="bibr" rid="article-128626.r15">[15]</xref><xref ref-type="bibr" rid="article-128626.r16">[16]</xref>&#x000a0;</p>
        <p>Normal findings on bone scintigraphy include uniform uptake throughout the bony skeleton. Intense uptake at the kidneys and bladder (due to urinary excretion), sacroiliac joints, nasopharynx, sternum, and joint surfaces is also considered normal. Increased uptake&#x000a0;is also be seen in the physical state of skeletally immature individuals due to increased osteoblast activity.<xref ref-type="bibr" rid="article-128626.r17">[17]</xref></p>
        <p>Gallium-67 citrate binds to transferrin in the plasma, resulting in increased concentrations in areas of inflammation and increased local perfusion. In infection, increased concentrations of lactoferrin secreted from leukocytes bind Ga-67 at the inflammatory foci. Bacteria also produce Siderophores, which bind Ga-67 and are transported into the bacterium.<xref ref-type="bibr" rid="article-128626.r18">[18]</xref></p>
        <p>The uptake of Indium-111 and 99mTc-exametazime labeled leukocytes depends on several prerequisites, including an intact chemotaxis mechanism, an adequate number of labeled cells, and a baseline leukocyte count of at least 2000/microliter. The sensitivity of these tests is higher in neutrophil-mediated infections. Labeled leukocytes accumulate in the bone marrow due to phagocytosis by macrophages, and distribution within the marrow can be affected by age, fractures, hardware, or neoplasm.</p>
      </sec>
      <sec id="article-128626.s4" sec-type="Indications">
        <title>Indications</title>
        <p>
<bold><bold>Nuclear Medicine Imaging Indications:&#x000a0;</bold>Infections</bold>
</p>
        <p>
<bold>Osteomyelitis</bold>
</p>
        <p>All the nuclear medicine imaging modalities described above may be used to evaluate osteomyelitis. When bone scintigraphy is used, it is typically in the form of a 3-phase bone scan. When osteomyelitis is present, the bone scan demonstrates hyper-perfusion, hyperemia, and increased bone turnover levels at the infection site. The sensitivity of this imaging test for posttraumatic osteomyelitis is good, ranging from 89 to 100%; however, specificity is less than 10% in this setting.<xref ref-type="bibr" rid="article-128626.r19">[19]</xref>&#x000a0;</p>
        <p>The 3-phase bone scan also offers differentiation between osteomyelitis and cellulitis. Cellulitis shows strong uptake in phases&#x000a0;1 and 2, followed by weak uptake in the third phase, while osteomyelitis shows uptake in all phases. There is some evidence that adding a fourth phase to the scan may increase specificity, particularly in patients with peripheral vascular disease or diabetes mellitus.<xref ref-type="bibr" rid="article-128626.r20">[20]</xref>&#x000a0;Labeled leukocyte scintigraphy is also commonly used to diagnose osteomyelitis. The Indium-111 labeled leukocyte scan has a sensitivity of 91% and specificity of 97% for detecting osteomyelitis.<xref ref-type="bibr" rid="article-128626.r21">[21]</xref>&#x000a0;</p>
        <p>When intramedullary infection is suspected, this test should be performed with a 99mTc sulfur colloid scan to differentiate between active marrow and sites of infection. Labeled leukocytes have no inherent affinity for bone; therefore, this scan does not differentiate between bone and soft tissue infection. SPECT/CT, is a useful adjunct in investigating osteomyelitis, particularly with surrounding soft tissue infection. This imaging improves anatomic localization, providing better differentiation between osseous and soft tissue infections. SPECT/CT has similar overall sensitivity to triple-phase bone scans and labeled leukocyte scans but improves the accuracy of both exams when evaluating for osteomyelitis.<xref ref-type="bibr" rid="article-128626.r22">[22]</xref><xref ref-type="bibr" rid="article-128626.r23">[23]</xref>&#x000a0;</p>
        <p>FDG-PET is most useful in spinal osteomyelitis, demonstrating high sensitivity and specificity and excellent anatomic localization when performed as PET/CT. FDG-PET offers much higher sensitivity than labeled leukocytes in spinal osteomyelitis and higher specificity than combined Gallium/Bone scintigraphy protocols. In the workup of spinal osteomyelitis, FDG-PET offers a useful adjunct to MRI in patients with non-diagnostic MRI findings or contraindications to MRI, such as metallic implants.<xref ref-type="bibr" rid="article-128626.r24">[24]</xref></p>
        <p>
<bold>Periprosthetic joint infection&#x000a0;</bold>
</p>
        <p>Bone scintigraphy is limited in utility due to the inability to distinguish aseptic loosening and periprosthetic&#x000a0;joint&#x000a0;infection (PJI). Postoperative increased uptake on technetium-99m bone scintigraphy after total hip and knee arthroplasty may also be normal for up to 2 years due to bony remodeling around the implant. Bone scintigraphy is sensitive but not specific for PJI and is best used as a screening tool. Bone scintigraphy has been combined with gallium-67 scintigraphy or labeled leukocyte scans with variable results.<xref ref-type="bibr" rid="article-128626.r25">[25]</xref></p>
        <p>When combined with 99mTc sulfur colloid scans, labeled leukocyte scintigraphy offers higher sensitivity and specificity for PJI when combined with bone scintigraphy.<xref ref-type="bibr" rid="article-128626.r26">[26]</xref>&#x000a0;Delayed or late imaging, typically at 24 hours or more, is preferred when chronic PJI is suspected. The bacterial biofilm produced around implants slows the migration of leukocytes to the infected area, and the overall sensitivity and accuracy of the exam for PJI may be increased with delayed imaging.<xref ref-type="bibr" rid="article-128626.r27">[27]</xref>&#x000a0;</p>
        <p>Implantation of arthroplasty hardware may cause an abnormal distribution of hematopoietic bone marrow, complicating the interpretation of results. Adding a 99mTc-Sulfur Colloid scan may offer better discrimination of normal bone marrow and reactive leukocyte infiltrates in infection.<xref ref-type="bibr" rid="article-128626.r25">[25]</xref>&#x000a0;Three-phase bone scintigraphy combined with labeled leukocyte/sulfur colloid marrow scintigraphy is the current gold standard nuclear medicine imaging for PJI. It offers high sensitivity, specificity, and diagnostic accuracy for PJI.<xref ref-type="bibr" rid="article-128626.r28">[28]</xref></p>
        <p>
<bold>Diabetic foot infection</bold>
</p>
        <p>The most common nuclear medicine modalities used in diabetic foot infections are bone scintigraphy and labeled leukocyte scintigraphy, with the latter being the current gold standard. Loss of skin integrity in the form of a pedal ulcer can rapidly lead to underlying osteomyelitis. As seen with other forms of osteomyelitis, bone scans are highly sensitive but poorly specific. Attempts have been made to improve the accuracy of bone scans in diabetic infection, such as adding a late 4 phase, which demonstrates uptake in woven bone, which is common in osteomyelitis but seen in other conditions such as fractures and degenerative changes.</p>
        <p>Neuropathic conditions such as the Charcot joint may mimic osteomyelitis by demonstrating focal hyperperfusion, hyperemia, and bony uptake, making diagnosis challenging. In addition, fractures and degeneration are integral to the Charcot joint. Labeled leukocyte imaging also demonstrates increased uptake in the neuropathic Charcot joint, which has been attributed to increased conversion of fatty to hematopoietic marrow activity. Sulfur colloid imaging is a useful adjunct in these instances.&#x000a0;SPECT/CT may assist in differentiating soft tissue and bony infectious lesions. However, clear differentiation may be challenging due to the proximity of these structures in the foot.<xref ref-type="bibr" rid="article-128626.r29">[29]</xref></p>
        <p>
<bold>Trauma</bold>
</p>
        <p>Bone scintigraphy is sensitive for detecting bone remodeling, periostitis, and microfractures associated with bone stress injury.<xref ref-type="bibr" rid="article-128626.r30">[30]</xref>&#x000a0;These changes result in increased uptake on bone scintigraphy before changes can be seen on radiographs. Stress fractures of the tibia, metatarsals,&#x000a0;scaphoid, tarsal bones, and spine are the more common indications for a bone scan. Although MRI is the most common modality used to diagnose tibial stress fractures and is comparable to bone scintigraphy sensitivity, bone scintigraphy can provide prognostic information by determining whether active bone turnover is present at the fracture site.<xref ref-type="bibr" rid="article-128626.r31">[31]</xref></p>
        <p>Fractures of the pars interarticularis, or spondylolysis, are a common pediatric stress fracture, and early bony changes may not be evident on radiographs or computed tomography.<xref ref-type="bibr" rid="article-128626.r32">[32]</xref>&#x000a0;SPECT/CT allows for early diagnosis and prognostic information by assessing bone metabolism at the fracture site.<xref ref-type="bibr" rid="article-128626.r33">[33]</xref>&#x000a0;Patients with a positive SPECT/CT may have better outcomes following surgical repair of symptomatic spondylolysis.<xref ref-type="bibr" rid="article-128626.r34">[34]</xref>&#x000a0;MRI has replaced bone scintigraphy and SPECT/CT as the imaging for these injuries.</p>
        <p>Acute occult bony or soft tissue injuries in children, such as a toddler&#x02019;s tibia fracture, may be quickly and easily diagnosed with bone scintigraphy.<xref ref-type="bibr" rid="article-128626.r35">[35]</xref>&#x000a0;Radiographic changes may take 2&#x000a0;or 3 weeks to become evident in these injuries, and MRI is logistically challenging in young children due to the requirement that the patient lay still. In cases of suspected child abuse where missed injury can endanger the patient, bone scintigraphy can provide prompt evidence of musculoskeletal injury before radiographic changes are evident.<xref ref-type="bibr" rid="article-128626.r36">[36]</xref><xref ref-type="bibr" rid="article-128626.r37">[37]</xref></p>
        <p>Occult insufficiency fractures of the spinal column, sacrum, pelvis, and femoral head or neck may also be evaluated with bone scintigraphy, demonstrating increased uptake at the fracture site in delayed phases. SPECT/CT provides more precise anatomic localization. MRI has largely replaced these tests in this indication. However, bone scintigraphy provides a useful adjunct when MRI would be otherwise contraindicated or affected by metallic artifacts from implanted hardware at the site in question.<xref ref-type="bibr" rid="article-128626.r38">[38]</xref></p>
        <p>
<bold>Tumor</bold>
</p>
        <p>Bone scintigraphy has historically been the most common nuclear medicine imaging modality used in the workup of metastatic musculoskeletal disease. It is most commonly used to evaluate bony metastasis but is limited in specificity and anatomic localization. FDG-PET and PET/CT are now the mainstay nuclear medicine modalities for the identification and workup of both soft tissue and bony metastases and provide useful information for biopsy guidance, staging, response to therapy, and anatomic localization.<xref ref-type="bibr" rid="article-128626.r39">[39]</xref>&#x000a0;</p>
        <p>FDG-PET offers several advantages over bone scintigraphy and SPECT/CT. FDG is taken up directly by tumor cells, in contrast to 99mTc-MDP, which reflects changes in bone metabolism by a tumor. This direct uptake of FDG allows for more precise differentiation of active and healing lesions, giving a clearer picture of the response to therapy. FDG has no inherent affinity for bone and can also detect soft tissue metastases. FDG has a high affinity for osteolytic lesions such as renal and thyroid carcinoma, detecting these metastases with high sensitivity. It also identifies skeletal and extraskeletal lesions in multiple myeloma, where bone scintigraphy is poorly sensitive.</p>
        <p>Bone scintigraphy, in contrast, offers better sensitivity for detecting osteoblastic tumors and metastases such as prostate and small cell lung carcinoma. Patients with mixed lesions, such as in breast carcinoma, should, therefore, undergo both imaging tests. FDG-PET is now ubiquitous in the staging and surveillance of all types of lymphoma and detects intramedullary bony metastases more accurately than bone scintigraphy and bone marrow biopsy.<xref ref-type="bibr" rid="article-128626.r40">[40]</xref><xref ref-type="bibr" rid="article-128626.r41">[41]</xref></p>
        <p>
<bold>
<bold>
<bold>Nuclear&#x000a0;Medicine&#x000a0;Imaging: Less Common Indications</bold>
</bold>
</bold>
</p>
        <p>
<bold>Avascular necrosis</bold>
</p>
        <p>Bone scintigraphy may be used to assess bone vascularity in cases of suspected bone infarct. It is typically used to evaluate the femoral head, femoral condyles, and jaw. Changes seen on bone scintigraphy occur quickly compared to radiographs or MRIs and can be seen in less than 72 hours. Changes include the absence of uptake in affected areas, which may also include a ring of high uptake around the necrotic lesion, indicating reactive hyperemia. Labeled leukocyte scintigraphy and FDG-PET have little clinical utility in this condition.</p>
        <p>
<bold>Paget disease&#x02014;fibrous dysplasia</bold>
</p>
        <p>Bone scintigraphy may demonstrate well-delineated areas of intense bony uptake and hyperemia. The main indication for bone scintigraphy in this condition is the diagnosis of polyostotic involvement of fibrous dysplasia&#x02014;Paget disease results in diffuse intense uptake in affected bones. There is little evidence to support the utilization of bone scans to follow disease progression for either Paget disease or fibrous dysplasia.</p>
        <p>
<bold>Complex regional pain syndrome</bold>
</p>
        <p>Bone scintigraphy results in a characteristic finding of diffuse intense hyperemia of the affected area in the flow and blood pool phases, followed by a less common finding of peri-articular bony uptake in delayed phases. The presence of peri-articular uptake in the delayed phases is highly suggestive of the diagnosis.</p>
        <p>
<bold>Myositis ossificans and heterotopic ossification</bold>
</p>
        <p>Early extraskeletal bone formation shows poorly delineated areas of increased bone scintigraphy uptake that become less intense as the lesion matures. Myositis ossificans may continue to show increased uptake even after the lesion becomes stable enough for excision. Some evidence recommends against the exclusive use of bone scintigraphy to determine the timing of excision.<xref ref-type="bibr" rid="article-128626.r42">[42]</xref></p>
        <p>
<bold>Sports or overuse Injuries</bold>
</p>
        <p>Bone scintigraphy may be used for various injuries, including plantar fasciitis, Achilles or peroneal tendonitis, Osgood-Schlatter disease, and medial tibial stress syndrome.<xref ref-type="bibr" rid="article-128626.r43">[43]</xref></p>
      </sec>
      <sec id="article-128626.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>
<bold>Absolute Contraindications</bold>
</p>
        <p>
<bold>Bone scintigraphy</bold>
</p>
        <p>There are no absolute contraindications for bone scintigraphy. Relative contraindications exist, including pregnancy, physical size and weight limits of scanners, and recent nuclear medicine exams or therapy.<xref ref-type="bibr" rid="article-128626.r43">[43]</xref></p>
        <p>
<bold>Labeled leukocyte scintigraphy</bold>
</p>
        <p>There are no absolute contraindications to labeled leukocyte scintigraphy. Relative contraindications to labeled leukocyte scintigraphy include neutropenia or concurrent use of immunosuppressive therapy that interferes with leukocyte chemotaxis.</p>
        <p>
<bold>FDG-PET or PET/CT imaging</bold>
</p>
        <p>There are no absolute contraindications to FDG-PET or PET/CT imaging. Relative contraindications include a blood glucose level of greater than 120 mg/dL, the inability to lie still for the exam, the inability to place arms above the head, patient greater than the size or weight limit of the scanner, history of claustrophobia, or recent chemotherapy less than ten days before the exam.<xref ref-type="bibr" rid="article-128626.r44">[44]</xref></p>
      </sec>
      <sec id="article-128626.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>A single or dual-headed gamma camera with a high-resolution parallel hole collimator is required for bone scintigraphy. A pin-hole collimator may be used to acquire high-resolution images and is routinely used with pediatric patients. Obtaining SPECT imaging requires that the gamma camera be oriented in a 180-degree geometry between detector heads, and images are then obtained over 360 degrees in approximately 10 to 30 seconds. SPECT/CT requires the addition of a CT scanner with a combined gamma camera. Refrigeration of the tracer at 4 to 8 degrees Celsius may be required, depending on the brand used. Intravenous access is necessary for the administration of radiotracer.</p>
        <p>The radiolabeling of leukocytes for both In-111 and 99mTc-HMPAO scans requires a sterile field and appropriate sterile PPE. Labeling is usually completed in a sterile laminar flow cabinet or isolator. Intravenous access is required for the withdrawal of patient blood and the administration of the labeled leukocytes. Imaging equipment is essentially the same as bone scintigraphy, utilizing a planar gamma camera.</p>
        <p>FDG-PET and PET/CT scans require the appropriate scanner, and the latter uses a single system with a combined PET and CT scanner on a single table. In addition, intravenous access, a glucometer, and a patient scale are required. Images obtained from the scan must be processed using software approved for clinical use and evaluated on approved monitors with appropriate settings.</p>
      </sec>
      <sec id="article-128626.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>Radiology technologists who have completed training in the imaging modality to be performed are required to administer the radiotracers, operate the appropriate scanner with indicated protocols, and perform post-scan image reconstruction. A radiologist or nuclear medicine physician must analyze the images obtained and provide a report for the ordering service or clinician.</p>
      </sec>
      <sec id="article-128626.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>Before the procedure, the patient should be advised on the imaging test's risks and benefits and the exam's intended purpose in their clinical condition. Clear instructions for the day of the procedure should be provided to the patient before arrival to avoid potential complications and delays. A brief interval history should be taken on the day of the procedure to include any history of trauma, surgery, arthritis, pregnancy, cancer, bone disease, current medical conditions, prior imaging results, and any recent nuclear medicine therapy or imaging.</p>
        <p>
<bold>Bone Scintigraphy</bold>
</p>
        <p>The patient should be well hydrated and should void immediately before the exam. The radiopharmaceutical is prepared with sodium pertechnetate per manufacturer instructions and kept at the appropriate temperature. The radiopharmaceutical should not be exposed to air and should be injected within 6 hours of preparation. The tracer is administered. intravenously.</p>
        <p>The most commonly used protocol in bone scintigraphy is the 3-phase bone scan. This begins with the tracer injection described above, with the typical dose being 10 to 30 millicuries (mCi) for adults and 0.2 to 0.3 mCi per Kg for pediatric patients.<xref ref-type="bibr" rid="article-128626.r45">[45]</xref>&#x000a0;The first phase is a dynamic imaging sequence, or "flow phase," obtained from the moment of injection for approximately 60 seconds. This phase allows for evaluating the relative perfusion of the area of interest. This is immediately followed by a static imaging sequence or "pool phase," including soft tissue accumulation. The final or "bone phase" is typically scanned 2 to 5 hours after the initial injection, allowing for bony uptake and soft tissue clearance.<xref ref-type="bibr" rid="article-128626.r17">[17]</xref>&#x000a0;In some instances, when peripheral vascular disease or diabetes mellitus is present, a final&#x000a0;fourth phase can be imaged 24 hours after tracer injection to increase the accuracy of the exam.<xref ref-type="bibr" rid="article-128626.r20">[20]</xref></p>
        <p>
<bold>Labeled Leukocyte Imaging</bold>
</p>
        <p>Labeled leukocyte imaging requires special preparation of the leukocytes in a sterile field. The patient&#x02019;s blood is collected and mixed with a citrate-dextrose anticoagulant in a vial. The blood is then centrifuged at 2000 g for 10 min. After the pellet and blood-free plasma are separated, the pellet is mixed with 10% HES, and the erythrocytes are allowed to sediment. The remaining leukocyte-rich plasma is removed and re-centrifuged, and the pellet is placed into the blood-free plasma obtained at an earlier step. In-oxine or 99mTc-HMPAO is then added to this mixture for labeling. The labeled leukocytes should be reinjected into the patient within 3 hours of labeling.<xref ref-type="bibr" rid="article-128626.r46">[46]</xref>&#x000a0;</p>
        <p>Dosing is variable, but a common dose of 111In-labeled leukocytes is 300&#x000a0;to 500 &#x003bc;Ci, and a common dose of 99mTc-HMPAO&#x02013;labeled leukocytes is 5&#x000a0;to 10 mCi.<xref ref-type="bibr" rid="article-128626.r47">[47]</xref>&#x000a0;The imaging timing is also variable, from 1 to 30+ hours after injection, depending on the condition being investigated.&#x000a0;</p>
        <p>
<bold>FDG-PET</bold>
</p>
        <p>Patients should consume no food by mouth for at least 6 hours before the exam. Patients scheduled for morning exams should be instructed to remain NPO after midnight before the exam. Patients scheduled for afternoon tests should eat a light breakfast but have no oral intake after 8 AM. Patients should arrive hydrated after consuming at least 1 liter of water two hours before the exam. Blood glucose levels should be less than 120 mg/dl before administration of FDG. After injection, the patient should remain seated until the exam to minimize muscle activity. The patient should void 5 minutes before the start of the exam. The typical interval between FDG injection and image acquisition is 60 minutes. In combined systems, the PET and CT images are obtained concurrently. Reconstruction and processing are completed after the exam, and the images are evaluated using software to correlate areas of increased uptake with CT anatomy.</p>
      </sec>
      <sec id="article-128626.s9" sec-type="Complications">
        <title>Complications</title>
        <p>Complications are rare and are usually related to radionuclide administration, including venous extravasation or arterial injection. Allergic reactions are exceedingly rare but have been described.<xref ref-type="bibr" rid="article-128626.r48">[48]</xref></p>
      </sec>
      <sec id="article-128626.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Nuclear medicine imaging modalities can provide clinically useful information in the workup, diagnosis, and surveillance of many musculoskeletal conditions. In some instances, such as measuring tumor response to therapy or workup of infected implanted hardware, these nuclear medicine imaging tests offer advantages over conventional imaging. Nuclear medicine imaging provides the healthcare team with an alternative test when MRI or advanced conventional imaging is contraindicated. In many cases, it can be a complementary exam that offers the practitioner an alternate source of clinical data. In general, nuclear medicine imaging is less specific than conventional imaging and requires correlation with a thorough history and physical in the context of the specific diagnosis being investigated.</p>
      </sec>
      <sec id="article-128626.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The safe and successful utilization of any nuclear imaging modalities discussed above depends on expert knowledge from members of each discipline and careful communication among the healthcare team. This begins as early as the exam's ordering. Channels for dialogue with a nuclear medicine physician&#x000a0;should be established and accessible so an ordering physician can consider the diagnostic yield of a scan or patient appropriateness for a study in a given clinical scenario.</p>
        <p>The ordering clinician or practitioner is responsible for ensuring the test's appropriateness before subjecting the patient to its associated risks. During the imaging process, the patient inevitably encounters multiple handoffs of their care, using standardized handoff techniques, such as Situation, Background, Assessment, and Recommendation (SBAR) or an institution-specific model. Clear written instructions on preparing for the exam should be given to the patient before the exam day.&#x000a0;</p>
        <p>The highly technical nature of the exams also presents areas for interdisciplinary cooperation. For example, each radiotracer has a particular timeframe in which it must be administered following preparation. Coordination between the radiology technician preparing the radiotracer and the administering technician, who has insight into patient readiness for the exam, ensures the tracers prepared are neither wasted nor administered inappropriately. Timing when obtaining imaging is often crucial to produce satisfactory and clinically useful results.</p>
        <p>Depending on the purpose of the exam and the diagnosis being investigated, the imaging timing may be variable, even within an individual imaging modality. Clear communication between the ordering practitioner and the nuclear medicine physician about the indications for the exam and the information desired from the exam allows for the implementation of the appropriate imaging protocol.&#x000a0; &#x000a0;</p>
        <p>In the imaging suite, careful communication should continue between the radiology staff and the patient to ensure patient-centered care, patient&#x000a0;safety, and patient satisfaction. Unique circumstances may arise regarding patient handling of trauma patients in the scanner, for example, which require additional caution. Time should be protected before the exam for a full explanation of the procedure and answering patient questions, and established protocols performed to confirm the correct patient and anatomical site being investigated.<xref ref-type="bibr" rid="article-128626.r49">[49]</xref></p>
      </sec>
      <sec id="article-128626.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=128626&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=128626">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/128626/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=128626">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-128626.s13">
        <title>References</title>
        <ref id="article-128626.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Myers</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>The first radioindicator study in the life sciences with a man-made radionuclide: "Radioactive indicators in the study of phosphorus metabolism in rats, by O. Chievitz and G. Hevesy, reprinted from Nature 136: 754-755, Nov. 9, 1935.".</article-title>
            <source>J Nucl Med</source>
            <year>1975</year>
            <month>Dec</month>
            <volume>16</volume>
            <issue>12</issue>
            <fpage>1106</fpage>
            <page-range>1106-8</page-range>
            <pub-id pub-id-type="pmid">1104780</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DUDLEY</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>IMIRIE</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>ISTOCK</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Deposition of radiogallium (Ga72) in proliferating tissues.</article-title>
            <source>Radiology</source>
            <year>1950</year>
            <month>Oct</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>571</fpage>
            <page-range>571-8</page-range>
            <pub-id pub-id-type="pmid">14781365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MULRY</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>DUDLEY</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Studies of radiogallium as a diagnostic agent in bone tumors.</article-title>
            <source>J Lab Clin Med</source>
            <year>1951</year>
            <month>Feb</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>239</fpage>
            <page-range>239-52</page-range>
            <pub-id pub-id-type="pmid">14814350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DUDLEY</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>MARKOWITZ</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>MITCHELL</surname>
                <given-names>TG</given-names>
              </name>
            </person-group>
            <article-title>Studies of the localization of radioactive gallium (Ga72) in bone lesions.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1956</year>
            <month>Jun</month>
            <volume>38-A</volume>
            <issue>3</issue>
            <fpage>627</fpage>
            <page-range>627-37</page-range>
            <pub-id pub-id-type="pmid">13319417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Subramanian</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McAfee</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>A new complex of 99mTc for skeletal imaging.</article-title>
            <source>Radiology</source>
            <year>1971</year>
            <month>Apr</month>
            <volume>99</volume>
            <issue>1</issue>
            <fpage>192</fpage>
            <page-range>192-6</page-range>
            <pub-id pub-id-type="pmid">5548678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vijayanathan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Butt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gnanasegaran</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Groves</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Advantages and limitations of imaging the musculoskeletal system by conventional radiological, radionuclide, and hybrid modalities.</article-title>
            <source>Semin Nucl Med</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>39</volume>
            <issue>6</issue>
            <fpage>357</fpage>
            <page-range>357-68</page-range>
            <pub-id pub-id-type="pmid">19801216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Israel</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sandler</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Nuclear medicine is able to detect disease-related dysfunction.</article-title>
            <source>Semin Nucl Med</source>
            <year>2009</year>
            <month>Jul</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>234</fpage>
            <page-range>234-5</page-range>
            <pub-id pub-id-type="pmid">19497400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lavender</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Burn</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Chaudhri</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Gallium 67 citrate scanning in neoplastic and inflammatory lesions.</article-title>
            <source>Br J Radiol</source>
            <year>1971</year>
            <month>May</month>
            <volume>44</volume>
            <issue>521</issue>
            <fpage>361</fpage>
            <page-range>361-6</page-range>
            <pub-id pub-id-type="pmid">5108360</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raghavan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lazzeri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Palestro</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Imaging of Spondylodiscitis.</article-title>
            <source>Semin Nucl Med</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>131</fpage>
            <page-range>131-147</page-range>
            <pub-id pub-id-type="pmid">29452617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hung</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>The efficacy of <sup>18</sup>F-FDG PET/CT and <sup>67</sup>Ga SPECT/CT in diagnosing fever of unknown origin.</article-title>
            <source>Int J Infect Dis</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>62</volume>
            <fpage>10</fpage>
            <page-range>10-17</page-range>
            <pub-id pub-id-type="pmid">28652213</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palestro</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Love</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tronco</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Tomas</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Rini</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Combined labeled leukocyte and technetium 99m sulfur colloid bone marrow imaging for diagnosing musculoskeletal infection.</article-title>
            <source>Radiographics</source>
            <year>2006</year>
            <season>May-Jun</season>
            <volume>26</volume>
            <issue>3</issue>
            <fpage>859</fpage>
            <page-range>859-70</page-range>
            <pub-id pub-id-type="pmid">16702459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palestro</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Love</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The evolution of nuclear medicine and the musculoskeletal system.</article-title>
            <source>Radiol Clin North Am</source>
            <year>2009</year>
            <month>May</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>505</fpage>
            <page-range>505-32</page-range>
            <pub-id pub-id-type="pmid">19361673</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hess</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Blomberg</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>H&#x000f8;ilund-Carlsen</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Alavi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The pivotal role of FDG-PET/CT in modern medicine.</article-title>
            <source>Acad Radiol</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>232</fpage>
            <page-range>232-49</page-range>
            <pub-id pub-id-type="pmid">24439337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Subramanian</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McAfee</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Blair</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Kallfelz</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>FD</given-names>
              </name>
            </person-group>
            <article-title>Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.</article-title>
            <source>J Nucl Med</source>
            <year>1975</year>
            <month>Aug</month>
            <volume>16</volume>
            <issue>8</issue>
            <fpage>744</fpage>
            <page-range>744-55</page-range>
            <pub-id pub-id-type="pmid">170385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jones</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Francis</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Bone scanning: radionuclidic reaction mechanisms.</article-title>
            <source>Semin Nucl Med</source>
            <year>1976</year>
            <month>Jan</month>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-18</page-range>
            <pub-id pub-id-type="pmid">174228</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riggs</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Cooney</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Blood flow and bone uptake of 99mTc-labeled methylene diphosphonate.</article-title>
            <source>J Orthop Res</source>
            <year>1984</year>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>236</fpage>
            <page-range>236-43</page-range>
            <pub-id pub-id-type="pmid">6237181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Dinh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>McWhorter</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <chapter-title>Triple Phase Bone Scan</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">30571011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palestro</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Molecular Imaging of Infection: The First 50 Years.</article-title>
            <source>Semin Nucl Med</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>50</volume>
            <issue>1</issue>
            <fpage>23</fpage>
            <page-range>23-34</page-range>
            <pub-id pub-id-type="pmid">31843059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Govaert</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>IJpma</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>McNally</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McNally</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Reininga</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Glaudemans</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Accuracy of diagnostic imaging modalities for peripheral post-traumatic osteomyelitis - a systematic review of the recent literature.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>44</volume>
            <issue>8</issue>
            <fpage>1393</fpage>
            <page-range>1393-1407</page-range>
            <pub-id pub-id-type="pmid">28451827</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alazraki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dries</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Datz</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lawrence</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Value of a 24-hour image (four-phase bone scan) in assessing osteomyelitis in patients with peripheral vascular disease.</article-title>
            <source>J Nucl Med</source>
            <year>1985</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>7</issue>
            <fpage>711</fpage>
            <page-range>711-7</page-range>
            <pub-id pub-id-type="pmid">3159858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schauwecker</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>The scintigraphic diagnosis of osteomyelitis.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>1992</year>
            <month>Jan</month>
            <volume>158</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-18</page-range>
            <pub-id pub-id-type="pmid">1727365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eschmann</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Pfannenberg</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Storek</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vonthein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Claussen</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Bares</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Added value of SPECT/CT in patients suspected of having bone infection: preliminary results.</article-title>
            <source>Arch Orthop Trauma Surg</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>127</volume>
            <issue>3</issue>
            <fpage>211</fpage>
            <page-range>211-21</page-range>
            <pub-id pub-id-type="pmid">17146681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Filippi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schillaci</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Usefulness of hybrid SPECT/CT in 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections.</article-title>
            <source>J Nucl Med</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>47</volume>
            <issue>12</issue>
            <fpage>1908</fpage>
            <page-range>1908-13</page-range>
            <pub-id pub-id-type="pmid">17138732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palestro</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>FDG-PET in musculoskeletal infections.</article-title>
            <source>Semin Nucl Med</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>43</volume>
            <issue>5</issue>
            <fpage>367</fpage>
            <page-range>367-76</page-range>
            <pub-id pub-id-type="pmid">23905618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinski</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Estok</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Kavolus</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Nuclear Medicine Scans in Total Joint Replacement.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>2021</year>
            <month>Feb</month>
            <day>17</day>
            <volume>103</volume>
            <issue>4</issue>
            <fpage>359</fpage>
            <page-range>359-372</page-range>
            <pub-id pub-id-type="pmid">33369983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Love</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marwin</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Palestro</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Nuclear medicine and the infected joint replacement.</article-title>
            <source>Semin Nucl Med</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>66</fpage>
            <page-range>66-78</page-range>
            <pub-id pub-id-type="pmid">19038601</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larikka</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Ahonen</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Junila</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Niemel&#x000e4;</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>H&#x000e4;m&#x000e4;l&#x000e4;inen</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Syrj&#x000e4;l&#x000e4;</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Extended combined 99mTc-white blood cell and bone imaging improves the diagnostic accuracy in the detection of hip replacement infections.</article-title>
            <source>Eur J Nucl Med</source>
            <year>2001</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>288</fpage>
            <page-range>288-93</page-range>
            <pub-id pub-id-type="pmid">11315595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Signore</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sconfienza</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Borens</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Glaudemans</surname>
                <given-names>AWJM</given-names>
              </name>
              <name>
                <surname>Cassar-Pullicino</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Trampuz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Winkler</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gheysens</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Vanhoenacker</surname>
                <given-names>FMHM</given-names>
              </name>
              <name>
                <surname>Petrosillo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jutte</surname>
                <given-names>PC</given-names>
              </name>
            </person-group>
            <article-title>Consensus document for the diagnosis of prosthetic joint infections: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement).</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>46</volume>
            <issue>4</issue>
            <fpage>971</fpage>
            <page-range>971-988</page-range>
            <pub-id pub-id-type="pmid">30683987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palestro</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Love</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Nuclear medicine and diabetic foot infections.</article-title>
            <source>Semin Nucl Med</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-65</page-range>
            <pub-id pub-id-type="pmid">19038600</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sofka</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Imaging of stress fractures.</article-title>
            <source>Clin Sports Med</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <page-range>53-62, viii</page-range>
            <pub-id pub-id-type="pmid">16324973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zwas</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Elkanovitch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Frank</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Interpretation and classification of bone scintigraphic findings in stress fractures.</article-title>
            <source>J Nucl Med</source>
            <year>1987</year>
            <month>Apr</month>
            <volume>28</volume>
            <issue>4</issue>
            <fpage>452</fpage>
            <page-range>452-7</page-range>
            <pub-id pub-id-type="pmid">3572532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Congeni</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McCulloch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Swanson</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Lumbar spondylolysis. A study of natural progression in athletes.</article-title>
            <source>Am J Sports Med</source>
            <year>1997</year>
            <season>Mar-Apr</season>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>248</fpage>
            <page-range>248-53</page-range>
            <pub-id pub-id-type="pmid">9079183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryan</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Fogelman</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>The role of nuclear medicine in orthopaedics.</article-title>
            <source>Nucl Med Commun</source>
            <year>1994</year>
            <month>May</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>341</fpage>
            <page-range>341-60</page-range>
            <pub-id pub-id-type="pmid">8047320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raby</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mathews</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Symptomatic spondylolysis: correlation of CT and SPECT with clinical outcome.</article-title>
            <source>Clin Radiol</source>
            <year>1993</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>97</fpage>
            <page-range>97-9</page-range>
            <pub-id pub-id-type="pmid">8004904</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Sanderson</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Scintigraphy of toddler's fracture.</article-title>
            <source>J Nucl Med</source>
            <year>1988</year>
            <month>Dec</month>
            <volume>29</volume>
            <issue>12</issue>
            <fpage>2001</fpage>
            <page-range>2001-3</page-range>
            <pub-id pub-id-type="pmid">3193212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conway</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tanz</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Radkowski</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Anandappa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hernandez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>The role of bone scintigraphy in detecting child abuse.</article-title>
            <source>Semin Nucl Med</source>
            <year>1993</year>
            <month>Oct</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>321</fpage>
            <page-range>321-33</page-range>
            <pub-id pub-id-type="pmid">8256139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mandelstam</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fitzgerald</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ditchfield</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Complementary use of radiological skeletal survey and bone scintigraphy in detection of bony injuries in suspected child abuse.</article-title>
            <source>Arch Dis Child</source>
            <year>2003</year>
            <month>May</month>
            <volume>88</volume>
            <issue>5</issue>
            <fpage>387</fpage>
            <page-range>387-90; discussion 387-90</page-range>
            <pub-id pub-id-type="pmid">12716705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tang</surname>
                <given-names>ZB</given-names>
              </name>
              <name>
                <surname>Lei</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>Value of bone scan imaging in determining painful vertebrae of osteoporotic vertebral compression fractures patients with contraindications to MRI.</article-title>
            <source>Orthop Surg</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>172</fpage>
            <page-range>172-6</page-range>
            <pub-id pub-id-type="pmid">22927151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Etchebehere</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Hobbs</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Milton</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Malawi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Macapinlac</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Assessing the role of &#x000b9;&#x02078;F-FDG PET and &#x000b9;&#x02078;F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2016</year>
            <month>May</month>
            <volume>43</volume>
            <issue>5</issue>
            <fpage>860</fpage>
            <page-range>860-870</page-range>
            <pub-id pub-id-type="pmid">26631240</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El-Galaly</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Villa</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gormsen</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Baech</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cheah</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>FDG-PET/CT in the management of lymphomas: current status and future directions.</article-title>
            <source>J Intern Med</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>284</volume>
            <issue>4</issue>
            <fpage>358</fpage>
            <page-range>358-376</page-range>
            <pub-id pub-id-type="pmid">29989234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moog</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kotzerke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Reske</surname>
                <given-names>SN</given-names>
              </name>
            </person-group>
            <article-title>FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma.</article-title>
            <source>J Nucl Med</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>40</volume>
            <issue>9</issue>
            <fpage>1407</fpage>
            <page-range>1407-13</page-range>
            <pub-id pub-id-type="pmid">10492357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walczak</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Howe</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Myositis Ossificans.</article-title>
            <source>J Am Acad Orthop Surg</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>23</volume>
            <issue>10</issue>
            <fpage>612</fpage>
            <page-range>612-22</page-range>
            <pub-id pub-id-type="pmid">26320160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van den Wyngaert</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Strobel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kampen</surname>
                <given-names>WU</given-names>
              </name>
              <name>
                <surname>Kuwert</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>van der Bruggen</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mohan</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Gnanasegaran</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Delgado-Bolton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Beheshti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Langsteger</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Giammarile</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mottaghy</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Paycha</surname>
                <given-names>F</given-names>
              </name>
              <collab>EANM Bone &#x00026; Joint Committee and the Oncology Committee</collab>
            </person-group>
            <article-title>The EANM practice guidelines for bone scintigraphy.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>9</issue>
            <fpage>1723</fpage>
            <page-range>1723-38</page-range>
            <pub-id pub-id-type="pmid">27262701</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boellaard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>O'Doherty</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Mottaghy</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Lonsdale</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Stroobants</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Oyen</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Kotzerke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hoekstra</surname>
                <given-names>OS</given-names>
              </name>
              <name>
                <surname>Pruim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Marsden</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Tatsch</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hoekstra</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Visser</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Arends</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Verzijlbergen</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Zijlstra</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Comans</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Lammertsma</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Paans</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Willemsen</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Beyer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bockisch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schaefer-Prokop</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Delbeke</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Chiti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>181</fpage>
            <page-range>181-200</page-range>
            <pub-id pub-id-type="pmid">19915839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r45">
          <label>45</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Adams</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Banks</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <chapter-title>Bone Scan</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>14</day>
            <pub-id pub-id-type="pmid">30285381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seabold</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Forstrom</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Schauwecker</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Datz</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>McAfee</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Palestro</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Royal</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <article-title>Procedure guideline for indium-111-leukocyte scintigraphy for suspected infection/inflammation. Society of Nuclear Medicine.</article-title>
            <source>J Nucl Med</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>6</issue>
            <fpage>997</fpage>
            <page-range>997-1001</page-range>
            <pub-id pub-id-type="pmid">9189160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Love</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Palestro</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Radionuclide imaging of infection.</article-title>
            <source>J Nucl Med Technol</source>
            <year>2004</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>47</fpage>
            <page-range>47-57; quiz 58-9</page-range>
            <pub-id pub-id-type="pmid">15175400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Moon</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>An unusual case of anaphylaxis after fluorine-18-labeled fluorodeoxyglucose injection.</article-title>
            <source>Nucl Med Mol Imaging</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>201</fpage>
            <page-range>201-4</page-range>
            <pub-id pub-id-type="pmid">24900108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-128626.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <collab>European Society of Radiology&#x000a0;(ESR)</collab>
            <collab>European Federation of Radiographer Societies (EFRS)</collab>
            <article-title>Patient Safety in Medical Imaging: a joint paper of the European Society of Radiology (ESR) and the European Federation of Radiographer Societies (EFRS).</article-title>
            <source>Insights Imaging</source>
            <year>2019</year>
            <month>Apr</month>
            <day>05</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <pub-id pub-id-type="pmid">30949870</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
